|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.75 EUR | -2.99% |
|
+2.25% | +6.81% |
| Feb. 12 | Fagron NV Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Feb. 12 | Fagron FY free cash flow EUR 125.9 million | RE |
| Capitalization | 1.67B 1.98B 1.52B 1.45B 2.69B 179B 2.8B 17.68B 7.02B 86.5B 7.42B 7.26B 302B | P/E ratio 2025 * |
18x | P/E ratio 2026 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise value | 1.96B 2.32B 1.79B 1.71B 3.17B 211B 3.29B 20.78B 8.25B 102B 8.72B 8.54B 355B | EV / Sales 2025 * |
2.08x | EV / Sales 2026 * | 1.94x |
| Free-Float |
94.54% | Yield 2025 * |
1.73% | Yield 2026 * | 1.91% |
Last Transcript: Fagron N.V.
| 1 day | -2.99% | ||
| 1 week | +2.25% | ||
| Current month | +2.71% | ||
| 1 month | +4.60% | ||
| 3 months | +9.64% | ||
| 6 months | +9.11% | ||
| Current year | +6.81% |
| 1 week | 21.55 |  | 23.85 |
| 1 month | 21.55 | | 23.85 |
| Current year | 21.55 | | 23.85 |
| 1 year | 17.54 | | 23.85 |
| 3 years | 14.32 | | 23.85 |
| 5 years | 10.8 | | 23.85 |
| 10 years | 4.44 | | 23.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 2017-11-26 | |
Karin de Jong
DFI | Director of Finance/CFO | 47 | 2016-04-30 |
Vera Bakker
COO | Chief Operating Officer | 54 | 2022-05-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Karin de Jong
BRD | Director/Board Member | 47 | 2016-04-30 |
Koen Hoffman
CHM | Chairman | 58 | 2017-05-08 |
| Director/Board Member | 48 | 2018-02-06 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | +2.25% | +15.02% | +52.48% | 1.98B | |
| +0.33% | -1.72% | +19.29% | +196.80% | 929B | |
| -0.45% | +1.44% | +54.82% | +49.59% | 587B | |
| +1.76% | +3.61% | +19.67% | +50.59% | 409B | |
| +0.08% | +1.01% | +20.89% | +28.94% | 374B | |
| +1.42% | +7.19% | +26.36% | +32.36% | 320B | |
| +1.08% | +4.32% | +27.98% | +55.61% | 311B | |
| +1.82% | -0.43% | +43.82% | +10.83% | 301B | |
| +1.32% | +5.11% | -45.12% | -37.51% | 219B | |
| +1.52% | -3.94% | +24.32% | +51.52% | 199B | |
| Average | +0.59% | +2.02% | +20.70% | +49.12% | 365.06B | |
| Weighted average by Cap. | +0.74% | +1.58% | +24.99% | +75.73% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 944M 1.12B 861M 822M 1.53B 101B 1.58B 10.01B 3.97B 48.99B 4.2B 4.11B 171B | 1.04B 1.24B 952M 909M 1.69B 112B 1.75B 11.08B 4.4B 54.2B 4.65B 4.55B 189B |
| Net income | 93.9M 111M 85.65M 81.77M 152M 10.09B 158M 996M 395M 4.87B 418M 409M 17.04B | 111M 131M 101M 96.46M 179M 11.91B 186M 1.18B 467M 5.75B 493M 483M 20.1B |
| Net Debt | 292M 347M 267M 255M 473M 31.42B 491M 3.1B 1.23B 15.17B 1.3B 1.27B 53.03B | 358M 425M 326M 312M 578M 38.46B 601M 3.8B 1.51B 18.57B 1.59B 1.56B 64.91B |
Employees
3,989
Sector
Pharmaceuticals
Calendar
May. 10
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-13 | 22.75 € | -2.99% | 125,671 |
| 26-02-12 | 23.45 € | +8.56% | 312,822 |
| 26-02-11 | 21.60 € | -1.59% | 124,975 |
| 26-02-10 | 21.95 € | 0.00% | 77,462 |
| 26-02-09 | 21.95 € | -1.35% | 83,100 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
22.75EUR
Average target price
26.75EUR
Spread / Average Target
+17.58%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FAGR Stock
Select your edition
All financial news and data tailored to specific country editions
